Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine.
Publication
, Conference
Sekeres, MA; Allen, SL; Mohan, SR; Lundberg, AS; Erba, HP
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
6582 / 6582
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sekeres, M. A., Allen, S. L., Mohan, S. R., Lundberg, A. S., & Erba, H. P. (2010). Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine. In Journal of Clinical Oncology (Vol. 28, pp. 6582–6582). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.6582
Sekeres, M. A., S. L. Allen, S. R. Mohan, A. S. Lundberg, and H. P. Erba. “Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine.” In Journal of Clinical Oncology, 28:6582–6582. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.6582.
Sekeres MA, Allen SL, Mohan SR, Lundberg AS, Erba HP. Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 6582–6582.
Sekeres, M. A., et al. “Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 6582–6582. Crossref, doi:10.1200/jco.2010.28.15_suppl.6582.
Sekeres MA, Allen SL, Mohan SR, Lundberg AS, Erba HP. Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 6582–6582.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
6582 / 6582
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences